Morgan Stanley and Leerink partners provided buy ratings and target prices for AgomAb Therapeutics on June 29, 2026.

The entities involved

• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• Leerink partners →

  U.S. investment bank

  • Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Mon 08:52
  • A filing required by the SEC concerning McKesson Corporation shares, accompanied by analyst commentary.Sun 22:38

Related events

• Morgan Stanley provided price targets and ratings for Booking Holdings on September 22, 2026.Sep 22
• Morgan Stanley issued a rating and price target for Trevi Therapeutics, Inc. on August 28, 2026.Aug 28
• An analyst firm has provided price target recommendations for Universal Health Services.Sep 21
• Morgan Stanley increased price target and rating for Omnicom Group.Aug 26
• Morgan Stanley maintained its Buy rating and raised the price target for Lloyds Banking Group on September 12, 2026.Sep 12